Jeffrey Alan Zuckerman – Trademark Portfolio
Entity Type: 01
Jeffrey Alan Zuckerman holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include OPTIAGING and OPTIENVEJECIMIENTO. The owner is based in Fairbanks, AK.
Suite D
Fairbanks, AK 99709
Showing of trademarks Trademarks
Trademark Classifications
Jeffrey Alan Zuckerman's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Jeffrey Alan Zuckerman have?
Jeffrey Alan Zuckerman has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Jeffrey Alan Zuckerman file in?
Jeffrey Alan Zuckerman files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Jeffrey Alan Zuckerman's most well-known trademarks?
Jeffrey Alan Zuckerman's registered trademark portfolio includes well-known marks such as OPTIAGING and OPTIENVEJECIMIENTO. These are among 3 currently registered trademarks in the portfolio.
What is Jeffrey Alan Zuckerman's trademark registration success rate?
Jeffrey Alan Zuckerman has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.